These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


305 related items for PubMed ID: 17984815

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Nevirapine-associated rash in a Jamaican child with HIV/AIDS.
    Steel-Duncan JC, Pierre R, Gabay L, Christie CD.
    West Indian Med J; 2004 Oct; 53(5):356-8. PubMed ID: 15675504
    [Abstract] [Full Text] [Related]

  • 5. Desensitization to Nevirapine.
    TreatmentUpdate; 1999 Nov 01; 11(8):5. PubMed ID: 11367044
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Gender difference in Nevirapine-associated rash.
    Proj Inf Perspect; 1999 Apr 01; (27):11. PubMed ID: 11366728
    [Abstract] [Full Text] [Related]

  • 10. Nevirapine-induced rash with eosinophilia and systemic symptoms (DRESS).
    Gill S, Sagar A, Shankar S, Nair V.
    Indian J Pharmacol; 2013 Apr 01; 45(4):401-2. PubMed ID: 24014920
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Assessment of cetirizine, an antihistamine, to prevent cutaneous reactions to nevirapine therapy: results of the viramune-zyrtec double-blind, placebo-controlled trial.
    Launay O, Roudière L, Boukli N, Dupont B, Prévoteau du Clary F, Patey O, David F, Lortholary O, Devidas A, Piketty C, Rey E, Urbinelli R, Allaert FA, Tréluyer JM, Caumes E, Viramune-Zyrtec Study Group.
    Clin Infect Dis; 2004 Apr 15; 38(8):e66-72. PubMed ID: 15095233
    [Abstract] [Full Text] [Related]

  • 14. Oral adverse effects due to the use of Nevirapine.
    Moura MD, Senna MI, Madureira DF, Fonseca LM, Mesquita RA.
    J Contemp Dent Pract; 2008 Jan 01; 9(1):84-90. PubMed ID: 18176653
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Combined antiretroviral therapy with nevirapine of HIV-infected adults].
    Kravchenko AV.
    Ter Arkh; 2004 Jan 01; 76(11):68-71. PubMed ID: 15658542
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Severe hepatic failure related to nevirapine treatment.
    Cattelan AM, Erne E, Salatino A, Trevenzoli M, Carretta G, Meneghetti F, Cadrobbi P.
    Clin Infect Dis; 1999 Aug 01; 29(2):455-6. PubMed ID: 10476768
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.